Analyst Ratings for Jazz Pharmaceuticals PLC (JAZZ)

Updated: 2017-07-27

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) have received a consensus rating of Buy from Wall Street analysts. Last month, JAZZ received an average rating of Buy.

A buy rating was issued by 15 analysts, 0 gave an overweight rating, 3 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for JAZZ. The most optimistic price target was 210, implying potential capital gains of 32.38 percent. The most pessimistic price target was 144, which equates to a potential downside of -9.23 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes -4.87 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0.05 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -2.47 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

JAZZ has an estimated earnings growth rate of 9.61 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, although it is frequently more appropriate to compare PEG ratios to the company's peers. JAZZ has a PEG ratio of 2.53.

JAZZ has traded between a high of 163.75 and a low of 95.80 over the past year. Today's price is 65.59 percent above the 52-week low, and below the high by 3.12 percent. JAZZ has a P/E ratio of 24.29. Investors typically compare the P/E ratio to a company's peers in the industry. The JAZZ value stock report compares JAZZ to some of its peers using value stock charts. The market cap of JAZZ is $9.71 billion. JAZZ's next earnings release will be on 0000-00-00, which is days away.